Thebaine Market Report – Research, Industry Analysis Reports and Market Demands

Global Thebaine Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Thebaine Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Thebaine Consumption 2014-2024
- 2.1.2 Thebaine Consumption CAGR by Region
2.2 Thebaine Segment by Type
- 2.2.1 Food Grade
- 2.2.2 Pharmaceutical Grade
2.3 Thebaine Consumption by Type
- 2.3.1 Global Thebaine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Thebaine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Thebaine Sale Price by Type (2014-2019)
2.4 Thebaine Segment by Application
- 2.4.1 Oxymorphone
- 2.4.2 Nalbuphine
- 2.4.3 Naltrexone
- 2.4.4 Buprenorphine
- 2.4.5 Others
2.5 Thebaine Consumption by Application
- 2.5.1 Global Thebaine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Thebaine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Thebaine Sale Price by Application (2014-2019)

3 Global Thebaine by Players

3.1 Global Thebaine Sales Market Share by Players
- 3.1.1 Global Thebaine Sales by Players (2017-2019)
- 3.1.2 Global Thebaine Sales Market Share by Players (2017-2019)
3.2 Global Thebaine Revenue Market Share by Players
- 3.2.1 Global Thebaine Revenue by Players (2017-2019)
- 3.2.2 Global Thebaine Revenue Market Share by Players (2017-2019)
3.3 Global Thebaine Sale Price by Players
3.4 Global Thebaine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Thebaine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Thebaine Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Thebaine by Regions

4.1 Thebaine by Regions
- 4.1.1 Global Thebaine Consumption by Regions
- 4.1.2 Global Thebaine Value by Regions
4.2 Americas Thebaine Consumption Growth
4.3 APAC Thebaine Consumption Growth
4.4 Europe Thebaine Consumption Growth
4.5 Middle East & Africa Thebaine Consumption Growth

5 Americas

5.1 Americas Thebaine Consumption by Countries
- 5.1.1 Americas Thebaine Consumption by Countries (2014-2019)
- 5.1.2 Americas Thebaine Value by Countries (2014-2019)
5.2 Americas Thebaine Consumption by Type
5.3 Americas Thebaine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Thebaine Consumption by Countries
- 6.1.1 APAC Thebaine Consumption by Countries (2014-2019)
- 6.1.2 APAC Thebaine Value by Countries (2014-2019)
6.2 APAC Thebaine Consumption by Type
6.3 APAC Thebaine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Thebaine by Countries
- 7.1.1 Europe Thebaine Consumption by Countries (2014-2019)
- 7.1.2 Europe Thebaine Value by Countries (2014-2019)
7.2 Europe Thebaine Consumption by Type
7.3 Europe Thebaine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Thebaine by Countries
- 8.1.1 Middle East & Africa Thebaine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Thebaine Value by Countries (2014-2019)
8.2 Middle East & Africa Thebaine Consumption by Type
8.3 Middle East & Africa Thebaine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Thebaine Distributors
10.3 Thebaine Customer

11 Global Thebaine Market Forecast

11.1 Global Thebaine Consumption Forecast (2019-2024)
11.2 Global Thebaine Forecast by Regions
- 11.2.1 Global Thebaine Forecast by Regions (2019-2024)
- 11.2.2 Global Thebaine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Thebaine Forecast by Type
11.8 Global Thebaine Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.
Currently, because of the special properties of thebaine, subject to strict control in most countries, so the market production control by the country's policy.
Thebaine production industry is a highly profitable industry. In the United States and other regions, more and more enterprises begin to apply to enter this field, but the current situation, the market is still controlled by the Mallinckrodt Pharmaceuticals and Noramco.
But as the downstream drugs market gradually matures, the next few years, thebaine and his relevant market will gradually popular, so the next few years, thebaine have a certain degree of price rise, but the rate should be minimal

According to this study, over the next five years the Thebaine market will register a 1.1% CAGR in terms of revenue, the global market size will reach US$ 1240 million by 2024, from US$ 1160 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Thebaine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Thebaine market by product type, application, key manufacturers and key regions and countries.

This study considers the Thebaine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Food Grade
Pharmaceutical Grade
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oxymorphone
Nalbuphine
Naltrexone
Buprenorphine
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mallinckrodt Pharmaceuticals
Noramco
Alcaliber
Tasmanian Alkaloids
TPI
Cepia-Sanofi
Taj Pharmaceuticals
API Labs
Faran Shimi Pharmaceuticals
Gansu Alkaloids
Hwells

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Thebaine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Thebaine market by identifying its various subsegments.
Focuses on the key global Thebaine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Thebaine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Thebaine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.